CCL19 and neoplasm: Because the same chemokines that recruit anti-tumor leukocytes can also recruit pro-tumor leukocytes (for example CCL19 and CCL21 recruit both Tregs, mDCs, and activated T cells), therapeutically targeting chemokines or chemokine receptors in cancer is complicated.